Generic Medicine Info
Indications and Dosage
Cerebrovascular disorders
Adult: 2-4 mg bid

Angina pectoris
Adult: 8-16 mg/day

Adult: 4-16 mg/day; reduce dosage to a max of 8 mg in patients with cirrhosis or on cimetidine.
Cardiogenic shock, recent MI, unstable angina, severe renal impairment, CHF, aortic stenosis.
Adverse Reactions
Headache, peripheral oedema, dizziness, fatigue, flushing, paradoxical increase in ischaemic chest pain.
Drug Interactions
Increased hypotensive effects with other antihypertensive drugs such as β-blockers, some antipsychotics, ranitidine, and cimetidine.
Food Interaction
Increased bioavailability with grapefruit juice.
Description: Nilvadipine is a dihydropyridine calcium-channel blocker. It is a peripheral and coronary vasodilator, but has little or no effect on cardiac conduction and negative inotropic activity is rarely seen at therapeutic doses. It results in vasodilatation leading to reduced peripheral resistance, BP, and afterload, increased coronary blood flow, and a reflex increase in heart rate. This results in an increase in myocardial oxygen supply and cardiac output.
MIMS Class
Calcium Antagonists
Disclaimer: This information is independently developed by MIMS based on Nilvadipine from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to MIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, MIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2021 MIMS. All rights reserved. Powered by
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in